Pfizer starts trial of antiviral pill against COVID-19
Pfizer Inc has started a trial to evaluate its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.
Archives for September 28, 2021
Merck and Pfizer Wyeth settle vaccine patent dispute
Merck and Pfizer subsidiary, Wyeth LLC, have resolved a patent row related to their competing vaccines for preventing diseases including pneumonia and meningitis.
Bone Therapeutics inks iPSC related research partnership
A new deal sees Bone Therapeutics gain access to iPSC derived, genetically engineered MSCs.
Neurophth opens GMP manufacturing facility for gene therapy products in China
Neurophth Biotechnology Ltd. has opened a manufacturing facility at the Phase II Suzhou Biomedical Industrial Park (BioBAY) in Suzhou, China.
ViroCell and Great Ormond Street Hospital for Children address viral vector manufacturing bottleneck
ViroCell Biologics and Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) have formed a new partnership to immediately address the global viral vector manufacturing bottleneck for clinical trials